Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Flumequine Assays: Linking Topoisomerase II to Cell Fate
2026-09-09
Flumequine offers a mechanistic entry point for studying DNA topoisomerase II while revealing why biochemical inhibition and cellular drug response are not interchangeable. This article translates dissertation-level assay insights into a practical framework for DNA replication, DNA damage, and cancer research.
-
TET2 Metabolite Binding: STD NMR and Activity Assays
2026-09-08
Zhang, Cheng, and Ye present an integrated workflow that combines biochemical activity measurements with saturation transfer difference NMR to distinguish direct metabolite binding from functional regulation of human TET2. The protocol validates known TET2 activators and inhibitors and identifies glyoxylate as a direct, potentially inhibitory ligand, providing a practical framework for connecting cellular metabolism with epigenetic enzyme control.
-
(S)-(+)-Dimethindene maleate: M2 Workflow
2026-09-08
This practical guide explains how to evaluate (S)-(+)-Dimethindene maleate as a research antagonist for M2 muscarinic and histamine H1 receptor workflows, with attention to stock preparation, controls, and subtype interpretation. It is intended for controlled in vitro or ex vivo research and must not be used for diagnosis, treatment, or other medical applications.
-
Silybin A: An Assay-Ready Guide to Silymarin
2026-09-07
Silybin A offers a chemically defined way to study Silymarin biology without treating a complex extract as a single molecule. This guide connects stereochemical identity, solvent control, reference chemistry, and assay design for reproducible liver and metabolic research.
-
Ceapin-A7: A Translational Lens on ER Stress
2026-09-07
Ceapin-A7 enables branch-selective interrogation of ATF6α signaling, helping translational researchers distinguish ER stress mechanisms from downstream inflammatory and apoptotic effects. This article connects that experimental strategy with recent findings on PTX3–TLR4/NF-κB–FGF21 signaling in glucocorticoid-induced osteonecrosis.
-
Isoprenaline Hydrochloride in Cardiac Models
2026-09-05
Isoprenaline Hydrochloride, also called isoproterenol, is a non-selective β-adrenoceptor agonist for controlled β1- and β2-receptor activation. Product data and a 2026 mouse study support its use in cardiac, vascular, pulmonary, and heart–brain-axis research, while also defining important limits for dose interpretation and translation.
-
Tubastatin A: HDAC6 Inhibitor Workflow Guide
2026-09-04
Tubastatin A combines strong HDAC6 selectivity with practical readouts such as α-tubulin acetylation, inflammatory cytokines, and regulated cell-death markers. This guide translates porcine cardiac-arrest evidence into reproducible assay workflows while highlighting how the compound can support cancer biology, neuroprotection, and inflammation studies.
-
Small-Molecule Antagonists of Shh–Heparin Binding
2026-09-04
Lamson and colleagues used a high-throughput screen to identify small molecules that disrupt Sonic hedgehog N-terminal fragment binding to heparin and inhibit ligand-driven Hedgehog responses. The study establishes Shh–heparin interaction as a tractable target and uses Smoothened agonist rescue experiments to distinguish extracellular ligand antagonism from downstream pathway inhibition.
-
Trametinib: A Causal Assay Strategy for TERT
2026-09-03
Trametinib and GSK1120212 can do more than confirm MEK-ERK inhibition. This guide presents a causal assay strategy for separating pathway suppression, cell-cycle G1 arrest induction, and APEX2-dependent TERT regulation in oncology research.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-03
Grafton and colleagues combined high-content imaging, induced pluripotent stem cell-derived cardiomyocytes, and deep learning to detect cardiotoxic phenotypes across compound libraries. The study supports an early, target-agnostic screening strategy, while also showing why image-based signals require mechanistic and electrophysiological follow-up before translational interpretation.
-
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-09-02
This study identifies striatal D2 receptor-expressing medium spiny neurons as a cell-specific circuit substrate for autistic-like self-grooming and digging. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, it links Neuroligin 1 loss to D2-MSN hyperactivation and PKC-associated neuronal excitability.
-
Reserpine N1867: Practical Research Workflow
2026-09-02
Reserpine N1867 provides a defined research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and related neuropharmacology workflows, with documented identity, purity, solubility, and storage parameters. It should be used for controlled laboratory experiments only, not as evidence of clinical efficacy, a diagnostic material, or a source of universal assay dosing.
-
Pepstatin A Workflows for Protease Research
2026-09-01
Pepstatin A enables controlled interrogation of pepsin, renin, HIV protease, and cathepsin D in biochemical, viral, bone marrow, and receptor-trafficking workflows. This guide combines practical dosing, assay controls, and troubleshooting with a careful interpretation of how protease inhibition can complement GABA A receptor processing studies.
-
Tunicamycin: Turning ER Stress Into Translational Insight
2026-09-01
Tunicamycin is more than a laboratory stressor: as a potent N-glycosylation inhibitor, it provides a mechanistically defined way to study protein homeostasis, macrophage inflammation, and the adaptive limits of the unfolded protein response.
-
Hexetidine (NSC-17764) Lab Guide
2026-08-31
A scenario-based guide to using Hexetidine (NSC-17764), SKU BA1327, in antimicrobial, biofilm, and host-cell viability workflows. It explains concentration selection, solvent controls, assay interpretation, and practical supplier considerations without confusing microbial inhibition with mammalian cytotoxicity.